Jeffrey M. Fryer
Keine laufenden Positionen mehr
Vermögen: 1 Mio $ am 31.03.2024
Profil
Jeffrey M.
Fryer is the founder of Rallybio LLC and Rallybio Corp.
(founded in 2018).
At Rallybio Corp., he held the title of Chief Financial Officer & Treasurer until 2023.
He previously worked at Alexion Pharmaceuticals, Inc. as Chief Tax Officer & Vice President from 2008 to 2017.
Mr. Fryer has a graduate degree from the University of Hartford and an undergraduate degree from Bryant University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RALLYBIO CORPORATION
1,67% | 31.03.2023 | 632 370 ( 1,67% ) | 1 Mio $ | 31.03.2024 |
Ehemalige bekannte Positionen von Jeffrey M. Fryer
| Unternehmen | Position | Ende |
|---|---|---|
| RALLYBIO CORPORATION | Founder | 01.02.2023 |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.04.2017 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Founder | - |
Ausbildung von Jeffrey M. Fryer
| University of Hartford | Graduate Degree |
| Bryant University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
